Gender differences in coronary artery disease: Review of diagnostic challenges and current treatment

Postgraduate Medicine

Volumn 121, Issue 2, 2009, Pages 60-68

  Gopalakrishnan, Prabhakaran ^a   Ragland, Moluk Mirrasouli ^b   Tak, Tahir ^b,c  

^a JPS Health Network   (United States)

^b University of North Texas Health Science Center   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Cardiovascular disease; Coronary artery disease; Gender differences; Heart disease; Hormone replacement therapy; Women's health

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ESTROGEN; GESTAGEN; NARCOTIC AGENT; CARDIOVASCULAR AGENT;

ANGIOPLASTY; ARTICLE; CLINICAL FEATURE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAM; HEART CATHETERIZATION; HORMONE SUBSTITUTION; HUMAN; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; RISK FACTOR; SEX DIFFERENCE; DIAGNOSTIC IMAGING; ELECTROCARDIOGRAPHY; ESTROGEN THERAPY; FEMALE; INSTRUMENTATION; MALE; PROGNOSIS; REVIEW; SEXUAL DEVELOPMENT; WOMEN'S HEALTH;

CARDIOVASCULAR AGENTS; CORONARY DISEASE; DIAGNOSTIC IMAGING; ELECTROCARDIOGRAPHY; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MALE; PROGNOSIS; RISK FACTORS; SEX CHARACTERISTICS; SEX FACTORS; WOMEN'S HEALTH;

EID: 64849098908     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2009.03.1977     Document Type: Article

References (62)

1. Mosca L, Appel LJ, Benjamin EG, et al; American Heart Association. Evidence based guidelines for cardiovascular disease prevention in women. Circulation. 2004;109(5):672-693.
2. Mazzaferri EL, Limacher MC. Changing patterns of CAD therapy and hormone usage for women. Cardiology Review. 2005;22(3):32-37. (Pubitemid 40769131)
3. Lansky A. Outcomes of percutaneous and surgical revascularization in women. Prog Cardiovas Dis. 2004;46(4):305-319. (Pubitemid 38201293)
4. Hong S, Friedman J. The primary prevention of coronary heart disease in women: an overview. Cardiology Review. 2005;22(3):14-22. (Pubitemid 40769127)
5. Mosca L, Merz N, Blumenthal R, et al. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting. Circulation. 2005;111(4):488-493. (Pubitemid 40204434)
6. Mieres JH, Shaw LJ, Arai A, et al; Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation. 2005;111(5):682-696.
7. Bello N, Mosca L. Epidemiology of coronary heart disease in women. Prog Cardiovasc Dis. 2004;46(4):287-292. (Pubitemid 38201291)
8. Wenger NK. Cardiovascular health and disease in women - problems and prospects. Circulation. 2004;109:558-560.
9. Wenger NK. Coronary heart disease: the female heart is vulnerable. Prog Cardiovasc Dis. 2003;46(3):199-229. (Pubitemid 38028610)
10. Cohn J. Hormone replacement therapy revisited. Cardiology Review. 2005;22(3):40. (Pubitemid 40769132)
11. Berger JS, Brown DL. Impact of gender on mortality following primary angioplasty for acute myocardial infarction. Prog Cardiovasc Dis. 2004;46(4):297-304. (Pubitemid 38201292)
12. Peterson P, Masoudi F, Rumsfeld J. Gender differences in the epidemiology and treatment of heart failure. Cardiology Review. 2005;22(3):24-29. (Pubitemid 40769129)
13. Jacobs AK, Eckel RH. Evaluating and managing cardiovascular disease in women understanding a woman's heart. Circulation. 2005;111(4):383-384. (Pubitemid 40204417)
14. Redberg RF, Shaw LJ. Diagnosis of coronary artery disease in women. Prog Cardiovasc Dis. 2003;46(3):239-258. (Pubitemid 38021132)
15. Shaw LJ, Bairey Merz CN, Azziz R, et al. Postmenopausal women with a histoty of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health - National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab. 2008;93(4):1276-1284.
16. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3(2):213-219. (Pubitemid 26266496)
17. Wong ND, Pio J, Valencia R, Thakal G. Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III. Prev Cardiol. 2001;4(3):109-114. (Pubitemid 32613801)
18. Adams MR, Kaplan JR, Manuck SB, et al. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis. 1990;10(6):1051-1057.
19. Arant CB, Wessel TR, Olson MB, et al; National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. J Am Coll Cardiol. 2004;43(11):2009-2014.
20. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. N Engl J Med. 1999;341(4):217-225. (Pubitemid 29334519)
21. Hoffman LK, Ehrmann DA. Cardiometabolic features of polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab. 2008;4(4):215-222.
22. Lord J, Thomas R, Fox B, Acharya U, Wilkin T. The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome. BJOG. 2006;113(10):1203-1209. (Pubitemid 44401216)
23. Kolodgie FD, Virmani R, Burke AP, et al. Pathologic assessment of the vulnerable human coronary plaque. Heart. 2004;90(12):1385-1391. (Pubitemid 39626306)
24. Burke AP, Farb A, Malcom GT, Liang Y, Smialek J, Virmani R. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation. 1998;97(21):2110-2116. (Pubitemid 28262117)
25. Milner KA, Funk M, Arnold A, Vaccarino V. Typical symptoms are predictive of acute coronary syndromes in women. Am Heart J. 2002;143(2):283-288.
26. Milner KA, Funk M, Richards S, Wilmes R, Vaccarino V, Krumholz H. Gender differences in symptom presentation associated with coronary heart disease. Am J Cardiol. 1999;84(4):396-399. (Pubitemid 29398657)
27. Scirica BM, Moliterno DJ, Every NR, et al. Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators. Am J Cardiol. 1999;84(10):1145-1150. (Pubitemid 29507493)
28. Arnold AL, Milner KA, Vaccarino V. Sex and race differences in electrocardiogram use (the National Hospital Ambulatory Medical Care Survey). Am J Cardiol. 2001;88(9):1037-1040. (Pubitemid 33042621)
29. McCord J, Nowak RM, McCullough PA. Ninety-minute exclusion of acute myocardial infarcion by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation. 2001;104(13):1483-1488.
30. Wiviott SD, Cannon CP, Morrow DA, et al. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy. Circulation. 2004;109(5):580-586.
31. Gum PA, Kottke-Marchant K, Poggio ED, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol. 2001;88(3):230-235.
32. Lev EI, Patel RT, Maresh KJ, et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol. 2006;47(1):27-33.
33. Gan SC, Beaver SK, Houck PM, MacLehose RF, Lawson HW, Chan L. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med. 2000;343(1):8-15.
34. Abuful A, Gidron Y, Henkin Y. Physicians' attitudes toward preventive therapy for coronary artery disease: is there a gender bias? Clin Cardiol. 2005;28(8):389-393.
35. Mallik S, Vaccarino V. Outcomes of thrombolytic therapy for acute myocardial infarction in women. Prog Cardiovasc Dis. 2004;47(1):58-71.
36. Kwok Y, Kim C, Grady D, Segal M, Redberg R. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol. 1999;83(5):660-666.
37. Michaelides AP, Fourlas CA, Chatzistamatiou EI, Andrikopoulos GK, Soulis D, Psomadaki ZD, Stefanadis CI. QRS score improves diagnostic ability of treadmill exercise testing in women. Coron Artery Dis. 2007;18(4):313-318.
38. Webb CM, Rosano GM, Collins P. Oestrogen improves exercise-induced myocardial ischaemia in women. Lancet. 1998;351(9115):1556-1567.
39. Kawano H, Motoyama T, Ohgushi M, Kugiyama K, Ogawa H, Yasue H. Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina. Ann Intern Med. 2001;135(11):977-981.
40. Lloyd GW, Patel NR, McGing E, Cooper AF, Brennand-Roper D, Jackson G. Does angina vary with the menstrual cycle in women with premenopausal coronary artery disease? Heart. 2000;84(2):189-192.
41. Panting JR, Gatehouse PD, Yang GZ, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002;346(25):1948-1953.
42. Vermeltfoort IA, Bondarenko O, Raijmakers PG, et al. Is subendocardial ischaemia present in patients with chest pain and normal coronary angiograms? A cardiovascular MR study. Eur Heart J. 2007;28(13):1554-1558.
43. Buchthal SD, den Hollander JA, Merz CN, et al. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med. 2000;342(12):829-835.
44. Johnson BD, Shaw LJ, Buchthal SD; National Institutes of Health-National Heart, Lung, and Blood Institute. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation. 2004;109(24):2993-2999.
45. Wilson GT, Gopalakrishnan P, Tak T. Noninvasive cardiac imaging with computed tomography. Clin Med Res. 2007;5(3):165-171.
46. Gopalakrishnan P, Wilson GT, Tak T. Accuracy of multislice computed tomography coronary angiography: a pooled estimate. Cardiology Review. 2008;16(4):189-196.
47. Pundziute G, Schuijf JD, Jukema JW, et al. Gender influence on the diagnostic accuracy of 64-slice multislice computed tomography coronary angiography for detection of obstructive coronary artery disease. Heart. 2008;94(1):48-52.
48. Grodstein F, Stampfer MJ, Falkeborn M, Naessen T, Persson I. Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women. Epidemiology. 1999;10(5):476-480.
49. Varas-Lorenzo C, García-Rodríguez LA, Perez-Gutthann S, Duque-Oliart A. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study. Circulation. 2000;101(22):2572-2578.
50. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280(7):605-613.
51. Grady D, Herrington D, Bittner V; HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002;288(1):49-57.
52. Rossouw JE, Anderson GL, Prentice RL; Writing Group for the Women's Health Initiative Investigators, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333.
53. Anderson GL, Limacher M, Assaf AR; Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701-1712.
54. Cherry N, Gilmour K, Hannaford P; ESPRIT team. Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial. Lancet. 2002;360(9350):2001-2008.
55. Herrington DM, Reboussin DM, Brosnihan KB, et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med. 2000;343(8):522-529.
56. Schulman SP, Thiemann DR, Ouyang P, et al. Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina. J Am Coll Cardiol. 2002;39(2):231-237.
57. Barrett-Connor E. Hormones and heart disease in women: the timing hypothesis. Am J Epidemiol. 2007;166(5):506-510.
58. Hodis HN. Assessing benefits and risks of hormone therapy in 2008: new evidence, especially with regard to the heart. Cleve Clin J Med. 2008;75(suppl 4):S3-S12.
59. Rossouw JE, Prentice RL, Manson JF, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297(13):1465-1477.
60. Manson JE, Allison MA, Rossouw JE; WHI and WHI-CACS Investigators. Estrogen therapy and coronary-artery calcification. N Engl J Med. 2007;356(25):2591-2602.
61. Salpeter SR, Walsh JM, Greyber E, Salpeter EE. Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis. J Gen Intern Med. 2006;21(4):363-366.
62. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease. Committee on Gynecologic Practice. Obstet Gynecol. 2008;112(5):1189-1192.